Factors Associated with Medication-Related Burden Quality of Life (MRB-QoL) in Community-Dwelling Adults with Long-Term Conditions: An Exploratory Study

References

• Preston SH. Mortality Patterns in National Populations: With Special Reference to Recorded Causes of Death. New York: Academic. Press; 1976.
   Google Scholar
• Moser K, Shkolnikov V, Leon DA. World mortality 1950–2000: divergence replaces convergence from the late 1980s. Bull World Health Organ. 2005;83:202–209.
   PubMed Web of Science ®Google Scholar
• McMichael AJ, McKee M, Shkolnikov V, Valkonen T. Mortality trends and setbacks: global convergence or divergence? Lancet. 2004;363:1155–1159. doi:10.1016/S0140-6736(04)15902-3
   PubMed Web of Science ®Google Scholar
• Aston J, Wilson KA, Terry DRP. The treatment-related experiences of parents, children and young people with regular prescribed medication. Int J Clin Pharm. 2019;41:113–121. doi:10.1007/s11096-018-0756-z
   Web of Science ®Google Scholar
• Zhang S, Meng L, Qiu F, Yang JD, Sun S. Medication-related risk factors associated with health-related quality of life among community-dwelling elderly in China. Patient Prefer Adherence. 2018;12:529–537. doi:10.2147/PPA.S156713
   Web of Science ®Google Scholar
• van der Laan DM, Elders PJM, Boons CCLM, et al. The impact of cardiovascular medication use on patients’ daily lives: a cross-sectional study. Int J Clin Pharm. 2018;40:412–420. doi:10.1007/s11096-018-0601-4
   Web of Science ®Google Scholar
• Krska J, Katusiime B, Corlett SA. Patient experiences of the burden of using medicines for long‐term conditions and factors affecting burden: a cross‐sectional survey. Health Soc Care Community. 2018;26:946–959. doi:10.1111/hsc.12624
   PubMed Web of Science ®Google Scholar
• Mohammed MA, Moles RJ, Chen TF. Impact of pharmaceutical care interventions on health-related quality-of-life outcomes: a systematic review and meta-analysis. Ann Pharmacother. 2016;50(10):862–881. doi:10.1177/1060028016656016
   PubMed Web of Science ®Google Scholar
• Sakthong P, Suksanga P, Sakulbumrungsil R, Winit-Watjana W. Development of patient-reported outcomes measure of pharmaceutical therapy for Quality of Life (PROMPT-QoL): a novel instrument for medication management. Res Social Adm Pharm. 2015;11(3):315–338. doi:10.1016/j.sapharm.2014.10.002
   Web of Science ®Google Scholar
• Tseng HM, Lee CH, Chen YJ, Hsu HH, Huang LY, Huang JL. Developing a measure of medication-related quality of life for people with polypharmacy. Qual Life Res. 2016;25(5):1295–1302. doi:10.1007/s11136-015-1177-2
   Web of Science ®Google Scholar
• Mohammed MA, Moles RJ, Kouladjian L, Hilmer S, Chen TF. Development and validation of patient reported outcome measure of medication burden: the medication-related burden for quality of life (MRB-QoL) tool. BMJ Open. 2018;8:e018880. doi:10.1136/bmjopen-2017-018880
   Web of Science ®Google Scholar
• Montiel-Luque A, Nunez-Montenegro AJ, Martin-Aurioles E, Canca-Sanchez JC, Toro-Toro MC, Gonzalez-Correa JA. Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy. PLoS One. 2017;12(2):e0171320. doi:10.1371/journal.pone.0171320
   PubMed Web of Science ®Google Scholar
• Lalic S, Jamsen KM, Wimmer BC, et al. Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: a cross-sectional study. Eur J Clin Pharmacol. 2016;72(9):1117–1124. doi:10.1007/s00228-016-2075-4
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(12):1142–9.e1–2. doi:10.1016/j.amjmed.2009.02.021
   Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–787. doi:10.1001/archinte.167.8.781
   PubMedGoogle Scholar
• Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584–1591. doi:10.1177/0091270011421489
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68(1):97–105. doi:10.1111/j.1365-2125.2009.03411.x
   PubMed Web of Science ®Google Scholar
• Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6:2. doi:10.1136/bmjopen-2015-010035
   Web of Science ®Google Scholar
• Mohammed MA, Moles RJ, Chen TF. Pharmaceutical care and health related quality of life outcomes over the past 25 years: have we measured dimensions that really matter? Int J Clin Pharm. 2018;40:3–14. doi:10.1007/s11096-017-0582-8
   Web of Science ®Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995. doi:10.1016/j.jclinepi.2012.02.018
   PubMed Web of Science ®Google Scholar
• Turner JP, Jamsen KM, Shakib S, Singhal N, Prowse R, Bell JS. Polypharmacy cut-points in older people with cancer: how many medications are too many? Support Care Cancer. 2016;24(4):1831–1840. doi:10.1007/s00520-015-2970-8
   PubMed Web of Science ®Google Scholar
• George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–1376. doi:10.1345/aph.1D479
   PubMed Web of Science ®Google Scholar
• Templeton GF. A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research. Communications Assoc Information Systems. 2011;28(4):41–58. doi:10.17705/1CAIS.02804
   Google Scholar
• O’brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673–690. doi:10.1007/s11135-006-9018-6
   Web of Science ®Google Scholar
• Gnjidic D, Bell JS, Hilmer SN, Lonnroos E, Sulkava R, Hartikainen S. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med. 2012;44(5):458–467. doi:10.3109/07853890.2011.573499
   PubMed Web of Science ®Google Scholar
• Gallegos-Carrillo K, Garcia-Pena C, Mudgal J, Romero X, Duran-Arenas L, Salmeron J. Role of depressive symptoms and comorbid chronic disease on health-related quality of life among community-dwelling older adults. J Psychosom Res. 2009;66(2):127–135. doi:10.1016/j.jpsychores.2008.07.007
   PubMed Web of Science ®Google Scholar
• Zyoud SH, Daraghmeh DN, Mezyed DO, et al. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine. BMC Nephrol. 2016;17(1):44. doi:10.1186/s12882-016-0257-z
   Web of Science ®Google Scholar